{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:23:55Z","timestamp":1787837035850,"version":"build-2784847793"},"reference-count":27,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"unspecified","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province of China","doi-asserted-by":"crossref","award":["2024JJ1007"],"award-info":[{"award-number":["2024JJ1007"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province of China","doi-asserted-by":"crossref","award":["2024JJ9436"],"award-info":[{"award-number":["2024JJ9436"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010083","name":"Hunan Provincial Innovation Foundation for Postgraduate","doi-asserted-by":"publisher","award":["CX20251150"],"award-info":[{"award-number":["CX20251150"]}],"id":[{"id":"10.13039\/501100010083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010083","name":"Hunan Provincial Innovation Foundation for Postgraduate","doi-asserted-by":"publisher","award":["CX20251170"],"award-info":[{"award-number":["CX20251170"]}],"id":[{"id":"10.13039\/501100010083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010083","name":"Hunan Provincial Innovation Foundation for Postgraduate","doi-asserted-by":"publisher","award":["CX20251177"],"award-info":[{"award-number":["CX20251177"]}],"id":[{"id":"10.13039\/501100010083","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open Foundation of the Provincial and Ministerial Co-construction State Key Laboratory Cultivation Base for Traditional Chinese Medicine Powder and Innovative Drugs","award":["2022FTKFJJ06"],"award-info":[{"award-number":["2022FTKFJJ06"]}]},{"name":"Research Foundation of Education Bureau of Hunan Province of China","award":["20258052"],"award-info":[{"award-number":["20258052"]}]},{"name":"Research Foundation of Education Bureau of Hunan Province of China","award":["24A0272"],"award-info":[{"award-number":["24A0272"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,7,21]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Diabetic neuropathy is one of the most common and disabling complications of diabetes mellitus. Current management strategies are largely limited to glycaemic control and symptomatic relief, and few therapies have demonstrated definitive disease-modifying effects. Sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown multiple metabolic and vascular benefits. However, the efficacy and safety of SGLT2 inhibitors as adjunctive therapy for diabetic neuropathy have not yet been systematically evaluated. This protocol aims to describe the methodology for a systematic review and meta-analysis that will comprehensively assess the therapeutic value of SGLT2 inhibitors in diabetic neuropathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>A systematic search will be conducted in PubMed, Embase, Cochrane Library and Web of Science, as well as in clinical trial registries including the WHO International Clinical Trials Registry Platform and ClinicalTrials.gov, from database inception to 31 May 2026. Eligible studies will include randomised controlled trials evaluating SGLT2 inhibitors in combination with conventional therapy in patients with diabetic neuropathy. Two reviewers will independently perform study selection, data extraction and methodological quality assessment. Extracted data will include study characteristics, participant demographics, intervention details, outcome measures and adverse events. Risk of bias will be assessed using the Cochrane Risk of Bias 2 tool. Quantitative synthesis will be conducted using meta-analytic methods, with the choice of statistical model determined by the degree of heterogeneity, as assessed by Cochran\u2019s Q test and the I\u00b2 statistic. Where appropriate, meta-regression, subgroup analyses, sensitivity analyses and trial sequential analysis will be performed. Publication bias will be assessed using funnel plots and Egger\u2019s regression test, and the certainty of evidence will be evaluated using the Grading of Recommendations Assessment, Development and Evaluation approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval is not required because this study will involve only the analysis of published data. The findings will be disseminated through publication in a peer-reviewed journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD420261389933.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-122400","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:10:22Z","timestamp":1787836222000},"page":"e122400","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Sodium\u2013glucose cotransporter 2 inhibitors for diabetic neuropathy: a protocol for a systematic review and meta-analysis"],"prefix":"10.1136","volume":"16","author":[{"given":"Wang","family":"Tao","sequence":"first","affiliation":[{"name":"School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Yu","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9889-7668","authenticated-orcid":false,"given":"Xiangning","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawang","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of endocrinology, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0840-2797","authenticated-orcid":false,"given":"Rong","family":"Yu","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Xiao","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"2026082706101748000_16.8.e122400.1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev-med-043021-033114","article-title":"Spectrum of Diabetic Neuropathy: New Insights in Diagnosis and Treatment","volume":"75","author":"Dillon","year":"2024","journal-title":"Annu Rev Med"},{"key":"2026082706101748000_16.8.e122400.2","doi-asserted-by":"crossref","first-page":"102646","DOI":"10.1016\/j.autneu.2020.102646","article-title":"Cardiovascular autonomic neuropathy: A silent killer with long reach","volume":"225","author":"Ang","year":"2020","journal-title":"Auton Neurosci"},{"key":"2026082706101748000_16.8.e122400.3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","article-title":"Diabetic neuropathy","volume":"5","author":"Feldman","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2026082706101748000_16.8.e122400.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.0686"},{"key":"2026082706101748000_16.8.e122400.5","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/pedi.12633","article-title":"Cardiovascular autonomic neuropathy in adolescents and young adults with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Cohort Study","volume":"19","author":"Jaiswal","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"2026082706101748000_16.8.e122400.6","doi-asserted-by":"crossref","DOI":"10.1155\/pedi\/8398194","article-title":"Global Prevalence of Microvascular Complications in Children and Adolescents With Type 1 and Type 2 Diabetes: A Systematic Review and Meta-Analysis","volume":"2025","author":"Ezzatvar","year":"2025","journal-title":"Pediatr Diabetes"},{"key":"2026082706101748000_16.8.e122400.7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043554","article-title":"Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options","volume":"24","author":"Galiero","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026082706101748000_16.8.e122400.8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.029814","article-title":"Cardiac Autonomic Dysfunction and Risk of Silent Myocardial Infarction Among Adults With Type 2 Diabetes","volume":"12","author":"Kaze","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026082706101748000_16.8.e122400.9","first-page":"263","article-title":"Diabetic Gastroenteropathy: A Complication of Diabetes Mellitus","volume":"51","author":"Kurniawan","year":"2019","journal-title":"Acta Med Indones"},{"key":"2026082706101748000_16.8.e122400.10","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2042"},{"key":"2026082706101748000_16.8.e122400.11","doi-asserted-by":"crossref","first-page":"1265372","DOI":"10.3389\/fendo.2023.1265372","article-title":"Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment","volume":"14","author":"Zhu","year":"2024","journal-title":"Front Endocrinol"},{"key":"2026082706101748000_16.8.e122400.12","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2026.101248","article-title":"Sodium-Glucose Cotransporter-2 Inhibitors and Acute Kidney Injury Risk: A Systematic Review and Meta-Analysis of Randomized Trials","volume":"8","author":"Chiang","year":"2026","journal-title":"Kidney Med"},{"key":"2026082706101748000_16.8.e122400.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.11.031"},{"key":"2026082706101748000_16.8.e122400.14","doi-asserted-by":"crossref","DOI":"10.1111\/jns.70011","article-title":"Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study (DINE)","volume":"30","author":"Adhikari","year":"2025","journal-title":"J Peripher Nerv Syst"},{"key":"2026082706101748000_16.8.e122400.15","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.70128","article-title":"The Comparison of the Effect of Adding Empagliflozin to the Medication Regimen on Peripheral Neuropathy in Patients With Type II Diabetes: A Double Blind Randomised Clinical Trial","volume":"8","author":"Vafaeinasab","year":"2025","journal-title":"Endocrinol Diabetes Metab"},{"key":"2026082706101748000_16.8.e122400.16","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/ANNALS-25-01262","article-title":"Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists on Diabetic Foot Disease\u202f: An Emulated Target Trial","volume":"179","author":"Kristensen","year":"2026","journal-title":"Ann Intern Med"},{"key":"2026082706101748000_16.8.e122400.17","doi-asserted-by":"crossref","first-page":"101331","DOI":"10.1016\/j.diabet.2022.101331","article-title":"The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial","volume":"48","author":"Liao","year":"2022","journal-title":"Diabetes Metab"},{"key":"2026082706101748000_16.8.e122400.18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.926717","article-title":"The Outcomes of Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2I) on Diabetes-Associated Neuropathy: A Systematic Review and meta-Analysis","volume":"13","author":"Kandeel","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026082706101748000_16.8.e122400.19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"2026082706101748000_16.8.e122400.20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41574-025-01170-4","article-title":"Cardiometabolic and renal benefits of sodium-glucose cotransporter 2 inhibitors","volume":"21","author":"Lee","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"2026082706101748000_16.8.e122400.21","doi-asserted-by":"crossref","DOI":"10.3390\/antiox14030289","article-title":"The Impact of SGLT-2 Inhibitors on Hydroxyl Radical Markers and Diabetic Neuropathy: A Short-Term Clinical Study","volume":"14","author":"Klabuzai","year":"2025","journal-title":"Antioxidants (Basel)"},{"key":"2026082706101748000_16.8.e122400.22","doi-asserted-by":"crossref","first-page":"864332","DOI":"10.3389\/fendo.2022.864332","article-title":"Sodium Glucose Cotransporter-2 Inhibitor Protects Against Diabetic Neuropathy and Nephropathy in Modestly Controlled Type 2 Diabetes: Follow-Up Study","volume":"13","author":"Ishibashi","year":"2022","journal-title":"Front Endocrinol"},{"key":"2026082706101748000_16.8.e122400.23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/a-2640-9411","article-title":"The Therapeutic Potential of Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Neuropathy","volume":"133","author":"Panou","year":"2025","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2026082706101748000_16.8.e122400.24","article-title":"Therapeutic and Diagnostic Landscape of Diabetic Neuropathy: A Systematic Review of Clinical Studies","volume":"18","author":"Rajput","year":"2026","journal-title":"Cureus"},{"key":"2026082706101748000_16.8.e122400.25","doi-asserted-by":"crossref","first-page":"111335","DOI":"10.1016\/j.cellsig.2024.111335","article-title":"Sodium-glucose cotransporter 2 inhibitors and renin-angiotensin-aldosterone system, possible cellular interactions and benefits","volume":"122","author":"Forouzanmehr","year":"2024","journal-title":"Cell Signal"},{"key":"2026082706101748000_16.8.e122400.26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s13300-025-01828-2","article-title":"Innovative Diabetes Therapies and Impact on Peripheral and Autonomic Diabetic Neuropathies: A State-of-the-Art Review","volume":"17","author":"Vekic","year":"2026","journal-title":"Diabetes Ther"},{"key":"2026082706101748000_16.8.e122400.27","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26237213","article-title":"Neuroprotective Effect of SGLT2 Inhibitors","volume":"26","author":"Pawlos","year":"2021","journal-title":"Molecules"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-122400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:10:28Z","timestamp":1787836228000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-122400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,27]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bmjopen-2026-122400"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-122400","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}